ArticleMolecular cancer2015

OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.

Ichiyo Shibahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.